Essential clinical and laboratory data in the 3 families (A-C) and 6 sporadic patients with CDA type I
Patient/sex . | Year of birth . | Hb, g/L . | MCV, fL . | Retics, % or 109/L . | Bilirubin, mM . | sTK, U/L . | sTfR, U/L . | Ferritin, ng/mL . | Genotype . |
---|---|---|---|---|---|---|---|---|---|
A1/F | 1944 | 90 | 109 | — | 46 | — | — | 1341 | R1041W homozygote |
A2/M | 1956 | 112 | 98 | 5.0% | 32 | 99 | 9.1 | 812 | R1041W homozygote |
A3*/M | 1967 | 140 | 95 | — | — | 17 | 12.8 | — | R1041W homozygote |
A4/M | 1979 | 124 | 101 | — | 15 | 179 | 13.7 | 650 | R1041W homozygote |
A5/F | 1987 | 107 | 93 | 2.3% | 39 | 111 | 14 | 359 | R1041W homozygote |
A6/F | 1992 | 121 | 97 | — | — | 130 | 12.4 | — | R1041W homozygote |
A7/M | 1946 | 116 | 100 | — | — | 92 | 12.2 | — | R1041W homozygote |
A8/F | 1950 | 97 | 97 | — | — | 161 | 11.6 | — | R1041W homozygote |
A9/M | 1986 | 100 | 97 | — | — | 86 | 12.5 | — | R1041W homozygote |
B3/F | 1960 | 79 | 103 | 67 | 42 | 187 | 59.7 | 1184 | R1041W homozygote |
B7/M | 1974 | 88 | 105 | 54 | 110 | 222 | 57.1 | 1592 | R1041W homozygote |
C3/F | 1980 | 103 | 97 | 106 | — | 78 | 25.2 | 232 | WT/WT |
C5/F | 1973 | 77 | 95 | 61 | 63 | 88 | 43.5 | 260 | WT/WT |
E/M | 1929 | 112 | 104 | 27 | 77 | 44 | 35.2 | 766 | D1042/WT |
F/M | 1953 | 120 | 102 | 73 | 38 | 117 | 42.6 | 735 | P671L/WT |
G/F | 1950 | 82 | 104 | 15 | 27 | — | 11.4 | 1755 | N598S/R724W |
H/M | 1950 | 99 | 99 | 146 | 34 | 144 | 60.9 | 1190 | DeIV372/WT |
I/M | 1977 | 110 | 92 | 93 | 32 | 167 | 59.6 | 382 | WT/WT |
J/F | 1927 | 105 | 111 | 43 | 25 | — | 33.1 | 766 | P671L/WT |
Patient/sex . | Year of birth . | Hb, g/L . | MCV, fL . | Retics, % or 109/L . | Bilirubin, mM . | sTK, U/L . | sTfR, U/L . | Ferritin, ng/mL . | Genotype . |
---|---|---|---|---|---|---|---|---|---|
A1/F | 1944 | 90 | 109 | — | 46 | — | — | 1341 | R1041W homozygote |
A2/M | 1956 | 112 | 98 | 5.0% | 32 | 99 | 9.1 | 812 | R1041W homozygote |
A3*/M | 1967 | 140 | 95 | — | — | 17 | 12.8 | — | R1041W homozygote |
A4/M | 1979 | 124 | 101 | — | 15 | 179 | 13.7 | 650 | R1041W homozygote |
A5/F | 1987 | 107 | 93 | 2.3% | 39 | 111 | 14 | 359 | R1041W homozygote |
A6/F | 1992 | 121 | 97 | — | — | 130 | 12.4 | — | R1041W homozygote |
A7/M | 1946 | 116 | 100 | — | — | 92 | 12.2 | — | R1041W homozygote |
A8/F | 1950 | 97 | 97 | — | — | 161 | 11.6 | — | R1041W homozygote |
A9/M | 1986 | 100 | 97 | — | — | 86 | 12.5 | — | R1041W homozygote |
B3/F | 1960 | 79 | 103 | 67 | 42 | 187 | 59.7 | 1184 | R1041W homozygote |
B7/M | 1974 | 88 | 105 | 54 | 110 | 222 | 57.1 | 1592 | R1041W homozygote |
C3/F | 1980 | 103 | 97 | 106 | — | 78 | 25.2 | 232 | WT/WT |
C5/F | 1973 | 77 | 95 | 61 | 63 | 88 | 43.5 | 260 | WT/WT |
E/M | 1929 | 112 | 104 | 27 | 77 | 44 | 35.2 | 766 | D1042/WT |
F/M | 1953 | 120 | 102 | 73 | 38 | 117 | 42.6 | 735 | P671L/WT |
G/F | 1950 | 82 | 104 | 15 | 27 | — | 11.4 | 1755 | N598S/R724W |
H/M | 1950 | 99 | 99 | 146 | 34 | 144 | 60.9 | 1190 | DeIV372/WT |
I/M | 1977 | 110 | 92 | 93 | 32 | 167 | 59.6 | 382 | WT/WT |
J/F | 1927 | 105 | 111 | 43 | 25 | — | 33.1 | 766 | P671L/WT |
M indicates male; F, female; Hb, hemoglobin; sTK, serum thymidine kinase; sTfR, serum transferrin receptor; Retics, reticulocytes; and —, not done. Reference ranges: retics, 0.5%-3.8% (20-130 × 109/L); bilirubin, < 17 mM; sTK, 4.2-6.6 U/L; sTfR, 2.3-8.4 U/L; and ferritin, 22-402 ng/mL.
patient on interferon therapy.